Mid and South Essex NHS Foundation Trust (MSEFT) takes a big step in transformation of post-treatment care of patients recovering from cancer
Post-treatment cancer patients in mid and south Essex are to gain more control over their on-going care and support, thanks to a new remote digital monitoring platform.
MSEFT has commissioned an innovative web portal that will allow patients to benefit from “personalised care packages” after they have been treated for breast, colorectal or prostate cancer.
This will mean fewer hospital visits as they will now be able to keep in touch with their clinicians from the comfort of their homes. Crucially, they will have access to all the support, clinical advice and educational resources they need through an app or the portal. The new technology is particularly timely given “the new normal” resulting from the COVID-19 pandemic and the acceleration of virtual clinics.
“We want to improve the quality and impact of the care and support provided to patients living with – and beyond – cancer. These personalised care packages and the technology that will support them will mean patients are better informed about their disease, their treatment and the long-term effects of the cancer and their medication. Self-management services are tailored to individual needs and therefore help people return to living healthy and full lives as swiftly as possible.“
Michael Catling, MSEFT Group Director, Cancer
Clinicians will be able to track patients against their agreed care plan and retrieve and study their test results.
Remote personalised self-management and support is particularly appropriate for patients recovering from cancer who are at low risk of a relapse.
The innovative technology will initially be available to patients treated for three common types of cancer from the summer. It will be extended to other groups later.
The personalised care package available from the web portal will provide:
- A comprehensive plan for the patient’s longer term care and support after their treatment has ended and treatment summaries
- A cancer care review
- Good regular communication with clinicians so any risks can be identified early
- Health and wellbeing information and support.
From a clinical point of view, patient centred innovations such as this are fantastic. It empowers patients and enables us to all work together in a much more personalised way. We are all looking forward to seeing how this particular project develops.”
Dr Deepak Kumar, Macmillan GP
The Trust recently signed a contract with THERAPYAUDIT to provide the digital platform. It will be used by both GPs and hospital clinicians – ensuring everyone is contacted at appropriate times about any checks.
This puts MSEFT amongst the leaders in the East of England in establishing a remote access digital platform to support these patients, which is a priority for the national cancer programme.
“We are very pleased to be partnering with MSEFT by supplying technology that can help the Trust transform the care of patients recovering from cancer. It demonstrates how technology providers can work with committed clinicians to improve healthcare and give patients more control over their own recovery. This beetrootONCOLOGY service builds on our successful deployment of beetrootDMARD to the Trust.”
Christopher Wright, founder and CEO, THERAPYAUDIT Limited
The East of England Cancer Alliance Transformation Programme has provided £180,000 in funding to support the new model of care and the technology that underpins it.
Ends
For THERAPYAUDIT:
beetrootCANCER is the brand name of the digital health service being deployed
0800 756 1087
mseftpr@beetroothealth.com
The beetroot and THERAPYAUDIT logos are Registered Marks ®
More about beetrootCANCER here
